01
November
GLYCOVAX – A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines
GLYCOVAX – A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines
Full title: GLYCOVAX – A Training Network for the Rational Design of the Next Generation of Well-Defined Glycoconjugate Vaccines
Grantor: H2020 Marie Skłodowska- Curie ITN programme
Grant number: 675671
Grantor’s website: http://www.glycovax.eu/
Duration: 01.11.2015-31.10.2019
Coordinator: Novartis Vaccines and diagnostics S.R.L. (NVD), SIENA, Italy
Beneficiary: University of Rijeka Faculty of Medicine (MEDRI)
Total funding: EUR 3.560.797.00
Total funding (MEDRI): EUR 247.761.00
Brief description:
The project aims



